The global gastroretentive drug delivery systems market size was USD 4.9 Billion in 2022 and is expected to register a revenue CAGR of 9% over the forecast period, according to the latest report by Reports and Data.
Gastroretentive drug delivery devices serve to manage pharmaceutical release, offering maximum therapeutic efficacy, improved patient compliance, and fewer adverse effects. Furthermore, the aging population, which is becoming increasingly sensitive to chronic illnesses, is predicted to boost market revenue growth.
One of the primary challenges confronting the gastroretentive drug delivery industry is the complexity of the manufacturing process, which raises total production costs. This impediment is predicted to be solved through the development of cutting-edge pharmaceutical delivery systems and new technology. Increasing pharmaceutical corporations’ spending in R&D activities, on the other hand, will create appealing opportunities for market participants.
Additionally, increased adaption of advanced pharmaceutical medications, continuous research efforts to improve drug bioavailability, and market introduction of innovative and effective gastroretentive pharmaceuticals are boosting market revenue growth.
Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/6108
Some of the prominent players profiled in the global gastroretentive drug delivery systems market includes AbbVie Inc., Johnson & Johnson Services, Inc., Novartis AG, Pfizer, Inc., GlaxoSmithKline plc, Sanofi S.A., AstraZeneca plc, F. Hoffmann-La Roche AG, Merck & Co., Inc., and Allergan plc.
Some Key Highlights from the Report
- In 2022, the floating systems segment held the largest revenue share in the worldwide gastroretentive drug delivery system market. This is related to an increase in the prevalence of chronic illnesses such as GERD, peptic ulcer disease, and irritable bowel syndrome. Because floating system technology allows medicine to stay in the stomach for an extended period of time, it is frequently employed due to its simplicity and ease of use.
- During the projected period, the passive diffusion systems are anticipated to hold the highest revenue share in the global gastroretentive drug delivery system market. This can be attributed to the efficiency, cost-effectiveness, and relative simplicity of passive diffusion systems. These systems are designed to remain in the stomach for an extended duration, which facilitates the gradual and controlled release of the drug.
- It is predicted that the North American market will hold the largest revenue share in the global gastroretentive drug delivery systems market throughout the forecast period. This can be attributed to the elevated incidence of chronic disorders, such as diabetes and gastrointestinal issues, in the region.
- AstraZeneca plc. announced a collaboration with Daiichi Sankyo Company, Ltd. on July 27, 2020, to develop and sell a gastroretentive pharmaceutical delivery system for the treatment of breast cancer.
Read the full report @ https://www.reportsanddata.com/report-detail/gastroretentive-drug-delivery-systems-market
For the purpose of this report, Reports and Data has segmented the global gastroretentive drug delivery systems market on the basis of Technology Outlook, Application Outlook, Drug Release Mechanism Outlook, and Regional Outlook:
Technology Outlook (Revenue, USD Billion; 2022 – 2032)
- Floating Systems
- Mucoadhesive Systems
- Expandable Systems
- Other Technologies
Application Outlook (Revenue, USD Billion; 2022 – 2032)
- Gastric Ulcers
- Gastroesophageal Reflux Disease (GERD)
- Motility Disorders
- Other Applications
Drug Release Mechanism Outlook (Revenue, USD Billion; 2022-2032)
- Passive Diffusion Systems
- Active Diffusion Systems
- Olon Exchange Systems
- Other Mechanisms
Regional Outlook (Revenue, USD Billion; 2022-2032)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/6108
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyse consumer behaviour shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
